HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoji Shinkai Selected Research

Frailty

11/2023The relationship between working status in old age and cause-specific disability in Japanese community-dwelling older adults with or without frailty: A 3.6-year prospective study.
12/2022The Kesennuma Study in Miyagi, Japan: Study Design and Baseline Profiles of Participants.
12/2022Social frailty as social aspects of frailty: Research, practical activities, and prospects.
2/2021Low Dietary Variety and Diabetes Mellitus Are Associated with Frailty among Community-Dwelling Older Japanese Adults: A Cross-Sectional Study.
11/2020Associations of aging trajectories for an index of frailty score with mortality and medical and long-term care costs among older Japanese undergoing health checkups.
6/2020Healthy lifestyle behaviors and transitions in frailty status among independent community-dwelling older adults: The Yabu cohort study.
1/2020[Effects of a multifactorial intervention for improving frailty on risk of long-term care insurance certification, death, and long-term care cost among community-dwelling older adults: A quasi-experimental study using propensity score matching].
7/2019Cognitive frailty in community-dwelling older Japanese people: Prevalence and its association with falls.
5/2019Combined effect of diabetes and frailty on mortality and incident disability in older Japanese adults.
1/2019[Process and outcome evaluation of community-based strategies for frailty prevention in the elderly with the help of the senior workforce at Silver Human Resources Centers in Yabu City, Japan].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoji Shinkai Research Topics

Disease

15Frailty
11/2023 - 01/2011
6Cognitive Dysfunction
01/2021 - 07/2005
5Hypertension (High Blood Pressure)
01/2023 - 01/2012
5Myocardial Infarction
05/2017 - 05/2011
3Chronic Disease (Chronic Diseases)
11/2023 - 02/2016
3Sarcopenia
01/2023 - 03/2020
2Dementia (Dementias)
01/2019 - 10/2014
2Type 2 Diabetes Mellitus (MODY)
06/2018 - 10/2017
2Chronic Renal Insufficiency
07/2017 - 01/2017
2Macular Degeneration (Age-Related Maculopathy)
02/2016 - 04/2015
1Atrial Fibrillation
11/2017
1Xerostomia
09/2017
1Hyperuricemia
07/2017
1Hypertriglyceridemia
06/2017
1Hemorrhagic Stroke
06/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2017
1Aortic Aneurysm (Aneurysm, Aortic)
05/2017
1Stroke (Strokes)
01/2017
1Anemia
01/2017
1Mitochondrial Diseases (Mitochondrial Disease)
03/2016
1Pain (Aches)
01/2016
1Mobility Limitation (Difficulty Walking)
12/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
08/2010
1Infections
08/2010
1Inflammation (Inflammations)
10/2008
1Atherosclerosis
12/2004
1Urinary Incontinence
08/2004

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
11/2017 - 05/2017
5Serum AlbuminIBA
01/2021 - 08/2004
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2015
3Hemoglobins (Hemoglobin)IBA
05/2019 - 10/2017
3AlbuminsIBA
01/2019 - 01/2012
3Biomarkers (Surrogate Marker)IBA
03/2016 - 01/2011
3ButyrophilinsIBA
11/2011 - 07/2011
2Indicators and Reagents (Reagents)IBA
12/2022 - 09/2020
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2021 - 02/2016
2Vitamin DFDA LinkGeneric
01/2021 - 02/2016
2LipidsIBA
06/2018 - 05/2011
2Glucose (Dextrose)FDA LinkGeneric
10/2017 - 12/2014
2HDL CholesterolIBA
06/2017 - 10/2014
2P-2 (P 2)IBA
06/2017 - 05/2017
1PotassiumIBA
01/2023
1SodiumIBA
01/2023
1bis(N,N- dimethylhydroxamido)hydroxooxovanadateIBA
02/2021
1IronIBA
01/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
1Vitamin KFDA Link
01/2021
1Vitamin EFDA LinkGeneric
01/2021
1MagnesiumIBA
01/2021
1CalciumIBA
01/2021
1SilverIBA
01/2019
1Apolipoprotein E4IBA
01/2019
1ApolipoproteinsIBA
01/2019
1palladium chlorideIBA
10/2017
1CreatinineIBA
07/2017
1Uric Acid (Urate)IBA
07/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2017
1Triglycerides (Triacylglycerol)IBA
06/2017
1HDL LipoproteinsIBA
06/2017
1oxidized low density lipoproteinIBA
06/2017
1LDL CholesterolIBA
06/2017
1NucleotidesIBA
06/2017
1Epidermal Growth Factor (EGF)IBA
05/2017
1Fibronectins (Fibronectin)IBA
05/2017
1CholesterolIBA
01/2017
1Tocopherols (Tocopherol)IBA
02/2016
1ORALIT (ORS)IBA
02/2016
1ZincIBA
02/2016
1Carotenoids (Carotene)IBA
02/2016
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
02/2016
1Complement Factor H (Factor H)IBA
04/2015
1MicronutrientsIBA
10/2014
1Interleukin-6 (Interleukin 6)IBA
01/2011
1Immunoglobulin A (IgA)IBA
08/2010
1Secretory Immunoglobulin A (SIgA)IBA
08/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2008
1Retinaldehyde (Retinal)IBA
12/2004

Therapy/Procedure

7Activities of Daily Living (ADL)
11/2023 - 07/2005
4Long-Term Care
01/2023 - 01/2020
2Bite Force (Occlusal Forces)
01/2023 - 09/2017
1Home Nursing (Nursing, Home)
06/2020
1Glycemic Control
05/2019